A bispecific antibody targeting HER2 and CLDN18.2 eliminates gastric cancer cells expressing dual antigens by enhancing the immune effector function
Jingying Yue, Shuai Shao, Jie Zhou, Wenting Luo, XU Yan-ling, Qinbin Zhang, Jing Jiang, Marie M. Zhu
Topics & Concepts
Antibody-dependent cell-mediated cytotoxicityTrastuzumabMonoclonal antibodyCytotoxicityCancer researchAntibodyCancerImmune systemMedicineAntigenImmunologyChemistryIn vitroBreast cancerInternal medicineBiochemistryHER2/EGFR in Cancer ResearchMonoclonal and Polyclonal Antibodies ResearchGlycosylation and Glycoproteins Research